These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33371077)

  • 1. Platinum versus immunotherapy for unresectable esophageal cancer: A protocol for systematic review and meta analysis.
    Qian J; Tong Z; Zhang Y; Chen C
    Medicine (Baltimore); 2020 Dec; 99(51):e23537. PubMed ID: 33371077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative adjuvant therapy for resectable esophageal cancer: A protocol of a systematic review and meta-analysis.
    Chai T; Shen Z; Zhang P; Lin Y; Chen S; Zhang Z; Lin W; Kang M; Lin J
    Medicine (Baltimore); 2019 May; 98(20):e15485. PubMed ID: 31096448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A protocol for systematic review and meta analysis.
    Qian J; Tong Z; Zhang Y; Chen C
    Medicine (Baltimore); 2021 Jan; 100(3):e23802. PubMed ID: 33545943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant therapy for resectable early non-small cell lung cancer: A protocol for a systematic review and meta-analysis.
    Chai T; Zhang P; Lin Y; Zhang Z; Lin W; Kang M; Lin J
    Medicine (Baltimore); 2019 Jul; 98(30):e16468. PubMed ID: 31348250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum versus immunotherapy for early resectable non-small cell lung cancer: A protocol for systematic review and meta analysis.
    Tong Z; Luo F; Yang X; Kang M; Lin J
    Medicine (Baltimore); 2020 Oct; 99(43):e22349. PubMed ID: 33120735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of PD-1/PD-L1 Inhibitors versus platinum-based chemotherapy for the first-line treatment of advanced non-small cell lung cancer: a meta analysis of randomized controlled trials.
    Li ZQ; Yan HC; Gu JJ; Yang YL; Zhang MK; Fang XJ
    Pharmacol Res; 2020 Oct; 160():105194. PubMed ID: 32937178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arsenic trioxide combined with platinum drugs in treatment of cervical cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Pan D; Yang H; Huang J; He Z; Li H; Li D
    Medicine (Baltimore); 2020 Nov; 99(45):e22950. PubMed ID: 33157935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of PD-1 inhibitors in specific subgroups of patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of phase 3 randomized clinical trials.
    Lu Y; Wang W; Wang F
    Front Immunol; 2023; 14():1171671. PubMed ID: 37205107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of high risk factors (hot food, hot beverage, alcohol, tobacco, and diet) of esophageal cancer: A protocol for a systematic review and meta-analysis.
    Chai T; Shen Z; Zhang P; Lin Y; Chen S; Zhang Z; Lin W; Kang M; Lin J
    Medicine (Baltimore); 2019 Apr; 98(17):e15176. PubMed ID: 31027062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Rosa DD; Medeiros LR; Edelweiss MI; Bozzetti MC; Pohlmann PR; Stein AT; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005342. PubMed ID: 19588370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of neck anastomotic muscle flap embedded in 3-incision radical resection of oesophageal carcinoma: A protocol for systematic review and meta analysis.
    Tong Z; Yang X; Luo F; Zhu J; Kang M; Lin J
    Medicine (Baltimore); 2020 Oct; 99(41):e22263. PubMed ID: 33031267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
    Yu G; Yu W; Xu X; Ye B; Yao L
    PLoS One; 2021; 16(6):e0252829. PubMed ID: 34086821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines.
    Chen H; Yao X; Li T; Lam CW; Zhang H; Wang J; Zhang W; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Dec; 98(52):e18552. PubMed ID: 31876753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a systematic review and meta-analysis of Kang-ai injection for patients with oesophageal cancer.
    Song Q; Yang W; Meng Z; Wang J
    Medicine (Baltimore); 2020 Sep; 99(36):e22148. PubMed ID: 32899102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise medicine of programmed cell death-1/programmed cell death 1 ligand 1 inhibitor immunotherapy combined radiotherapy for inoperable advanced lung cancer: A protocol for systematic review and meta-analysis.
    Liu G; Lv X; Ding Y; Guo Y
    Medicine (Baltimore); 2021 Jun; 100(24):e26367. PubMed ID: 34128893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.
    Niglio SA; Jia R; Ji J; Ruder S; Patel VG; Martini A; Sfakianos JP; Marqueen KE; Waingankar N; Mehrazin R; Wiklund P; Oh WK; Mazumdar M; Ferket BS; Galsky MD
    Eur Urol; 2019 Dec; 76(6):782-789. PubMed ID: 31200951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.